403 related articles for article (PubMed ID: 12397885)
1. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
2. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
3. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
Manji HK; Chen G
Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
[TBL] [Abstract][Full Text] [Related]
4. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
5. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Chen G; Manji HK
Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
7. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention.
Charney DS; Manji HK
Sci STKE; 2004 Mar; 2004(225):re5. PubMed ID: 15039492
[TBL] [Abstract][Full Text] [Related]
8. Neuroplasticity and cellular resilience in mood disorders.
Manji HK; Moore GJ; Rajkowska G; Chen G
Mol Psychiatry; 2000 Nov; 5(6):578-93. PubMed ID: 11126389
[TBL] [Abstract][Full Text] [Related]
9. Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.
Quiroz JA; Manji HK
Dialogues Clin Neurosci; 2002 Mar; 4(1):73-92. PubMed ID: 22034240
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
[TBL] [Abstract][Full Text] [Related]
11. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
Bachmann RF; Schloesser RJ; Gould TD; Manji HK
Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281
[TBL] [Abstract][Full Text] [Related]
12. Critical role of brain-derived neurotrophic factor in mood disorders.
Hashimoto K; Shimizu E; Iyo M
Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
[TBL] [Abstract][Full Text] [Related]
14. New understanding of mechanisms of action of bipolar medications.
Sanacora G
J Clin Psychiatry; 2008; 69 Suppl 5():22-7. PubMed ID: 19265637
[TBL] [Abstract][Full Text] [Related]
15. [Neuroprotective actions of lithium].
Hashimoto R; Fujimaki K; Jeong MR; Senatorov VV; Christ L; Leeds P; Chuang DM; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(1):81-6. PubMed ID: 12701214
[TBL] [Abstract][Full Text] [Related]
16. The cellular neurobiology of depression.
Manji HK; Drevets WC; Charney DS
Nat Med; 2001 May; 7(5):541-7. PubMed ID: 11329053
[TBL] [Abstract][Full Text] [Related]
17. [Glia as targets for antidepressants: an involvement in glial cell line-derived neurotrophic factor].
Hisaoka K; Takebayashi M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Nov; 27(5-6):173-9. PubMed ID: 18154038
[TBL] [Abstract][Full Text] [Related]
18. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
Arantes-Gonçalves F; Coelho R
Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
[TBL] [Abstract][Full Text] [Related]
19. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
[TBL] [Abstract][Full Text] [Related]
20. [Neuroplasticity and depression].
Czéh B; Simon M
Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
